Pathologic Hypersecretory Conditions

• FDA approval · 2023-10-05
  FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved a supplemental application for Esomeprazole Magnesium from Mylan Pharmaceuticals, making a generic version of the proton pump i…

• FDA approval · 2022-06-03
  FDA Approved: FAMOTIDINE — Original Application (Zydus Lifesciences Limited)

  The FDA approved an original abbreviated new drug application (ANDA) for famotidine from Zydus Lifesciences Limited, making a generic versio…

• FDA approval · 2019-09-26
  FDA Approved: OMEPRAZOLE — Original Application (Camber Pharmaceuticals, Inc.)

  FDA approved Camber Pharmaceuticals' generic omeprazole in an Original Abbreviated New Drug Application, authorizing its use for the same in…

• FDA approval · 2016-07-15
  FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (Ajanta Pharma USA Inc.)

  FDA approves Ajanta Pharma USA Inc.'s original-application generic combination of omeprazole and sodium bicarbonate for acid-related disorde…

• FDA approval · 2016-02-10
  FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)

  FDA approved a supplemental application to authorize Good Neighbor Pharmacy Omeprazole (omeprazole) as a store-brand proton pump inhibitor m…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2015-01-02
  FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (NorthStar Rx LLC)

  The FDA approved a supplemental application for pantoprazole sodium filed by NorthStar Rx LLC.